Ackers-Johnson Matthew, Li Peter Yiqing, Holmes Andrew P, O'Brien Sian-Marie, Pavlovic Davor, Foo Roger S
From the Cardiovascular Research Institute, Centre for Translational Medicine MD6, National University Health System, Singapore (M.A.-J., P.Y.L., R.S.F.); Genome Institute of Singapore (M.A.-J., R.S.F.); and Institute of Cardiovascular Sciences, University of Birmingham, UK (A.P.H., S.-M.O., D.P.).
Circ Res. 2016 Sep 30;119(8):909-20. doi: 10.1161/CIRCRESAHA.116.309202. Epub 2016 Aug 8.
Cardiovascular disease represents a global pandemic. The advent of and recent advances in mouse genomics, epigenomics, and transgenics offer ever-greater potential for powerful avenues of research. However, progress is often constrained by unique complexities associated with the isolation of viable myocytes from the adult mouse heart. Current protocols rely on retrograde aortic perfusion using specialized Langendorff apparatus, which poses considerable logistical and technical barriers to researchers and demands extensive training investment.
To identify and optimize a convenient, alternative approach, allowing the robust isolation and culture of adult mouse cardiac myocytes using only common surgical and laboratory equipment.
Cardiac myocytes were isolated with yields comparable to those in published Langendorff-based methods, using direct needle perfusion of the LV ex vivo and without requirement for heparin injection. Isolated myocytes can be cultured antibiotic free, with retained organized contractile and mitochondrial morphology, transcriptional signatures, calcium handling, responses to hypoxia, neurohormonal stimulation, and electric pacing, and are amenable to patch clamp and adenoviral gene transfer techniques. Furthermore, the methodology permits concurrent isolation, separation, and coculture of myocyte and nonmyocyte cardiac populations.
We present a novel, simplified method, demonstrating concomitant isolation of viable cardiac myocytes and nonmyocytes from the same adult mouse heart. We anticipate that this new approach will expand and accelerate innovative research in the field of cardiac biology.
心血管疾病是一种全球性的流行病。小鼠基因组学、表观基因组学和转基因技术的出现及近期进展为强大的研究途径提供了越来越大的潜力。然而,进展往往受到与从成年小鼠心脏分离存活心肌细胞相关的独特复杂性的限制。目前的方案依赖于使用专门的Langendorff装置进行逆行主动脉灌注,这给研究人员带来了相当大的后勤和技术障碍,并且需要大量的培训投入。
确定并优化一种便捷的替代方法,仅使用普通的手术和实验室设备就能可靠地分离和培养成年小鼠心肌细胞。
通过对左心室进行离体直接针灌注,无需注射肝素,分离出的心肌细胞产量与已发表的基于Langendorff的方法相当。分离出的心肌细胞可以在无抗生素的条件下培养,保留有组织的收缩和线粒体形态、转录特征、钙处理能力、对缺氧的反应、神经激素刺激以及电起搏反应,并且适用于膜片钳和腺病毒基因转移技术。此外,该方法允许同时分离、分离和共培养心肌细胞和非心肌细胞群体。
我们提出了一种新颖、简化的方法,证明可以从同一只成年小鼠心脏中同时分离出存活的心肌细胞和非心肌细胞。我们预计这种新方法将扩大并加速心脏生物学领域的创新研究。